ArticleCureus2025
Challenges in Managing Brain Metastases From Merkel Cell Carcinoma in an Immunosuppressed Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumor with high rates of metastasis and poor prognosis. While MCC commonly metastasizes to the lymphatic system, distant central nervous system (CNS) involvement is unusual, often complicating early detection and treatment. We describe the case of a 58-year-old male with multiple comorbidities who presented with progressive left-sided weakness and disorientation. Imaging revealed a right frontal lesion with mass effect, and further scans identified an iliac and inguinal lymphadenopathy without a primary skin lesion. The initial inguinal lymph node biopsy was inconclusive, prompting surgical resection of the brain lesion. Histopathology confirmed neuroendocrine carcinoma with CK20 dot-like positivity, consistent with MCC. Despite interdisciplinary management, the patient experienced multiple complications, including a respiratory infection and progressive systemic deterioration, ultimately succumbing to septicemia. MCC with CNS metastasis is a rare and highly lethal condition. This case underlines the importance of early recognition and aggressive multidisciplinary management for potential improvement in prognosis, despite limited therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.